Olaplex (OLPX) shares plunge 7.59% on conflicting analyst reports and downgrades.

Olaplex Holdings Inc. (NASDAQ:OLPX) shares plunged 7.5862% in pre-market trading on Jan. 2, 2026, marking a sharp reversal after recent analyst activity highlighted diverging views on the stock. The decline follows a series of conflicting research reports from major firms, including a downgrade from Wall Street Zen to "sell" and a price target cut by Barclays to $1.25.

Institutional investor activity also contributed to the volatility, with Portolan Capital Management LLC and UBS Group AG significantly increasing stakes in the fourth quarter. The firm’s recent earnings report showed mixed results, including a 3.8% year-over-year revenue decline to $114.58 million, though it met EPS expectations. Analysts remain split, with one "strong-buy" rating and one "sell" rating currently outstanding.

Olaplex’s market capitalization stands at $894.46 million, with a 50-day moving average of $1.18. The stock’s elevated beta of 2.25 suggests heightened sensitivity to market swings, compounding risks amid a polarized analyst outlook. Institutional ownership now exceeds 87%, reflecting ongoing strategic repositioning by major investors.

Amid the uncertainty, traders and analysts are watching closely for any technical signals or fundamental developments that could provide clarity on the stock's future direction. Given its high volatility and mixed analyst sentiment, OLPX remains a high-risk investment with potential for significant swings in the near term.